- Home
- TRAK vs ENGN Comparison
TRAK vs ENGN Comparison
Compare TRAK & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAK
- ENGN
- Stock Information
- Founded
- TRAK 1990
- ENGN 1999
- Country
- TRAK United States
- ENGN Canada
- Employees
- TRAK N/A
- ENGN N/A
- Industry
- TRAK EDP Services
- ENGN
- Sector
- TRAK Technology
- ENGN
- Exchange
- TRAK Nasdaq
- ENGN Nasdaq
- Market Cap
- TRAK 374.5M
- ENGN 321.5M
- IPO Year
- TRAK 1998
- ENGN N/A
- Fundamental
- Price
- TRAK $17.22
- ENGN $6.52
- Analyst Decision
- TRAK
- ENGN Buy
- Analyst Count
- TRAK 0
- ENGN 8
- Target Price
- TRAK N/A
- ENGN $21.50
- AVG Volume (30 Days)
- TRAK 46.9K
- ENGN 225.5K
- Earning Date
- TRAK 11-13-2025
- ENGN 09-11-2025
- Dividend Yield
- TRAK 0.47%
- ENGN N/A
- EPS Growth
- TRAK 21.41
- ENGN N/A
- EPS
- TRAK 0.34
- ENGN N/A
- Revenue
- TRAK $22,028,373.00
- ENGN N/A
- Revenue This Year
- TRAK $15.18
- ENGN N/A
- Revenue Next Year
- TRAK $10.00
- ENGN N/A
- P/E Ratio
- TRAK $49.95
- ENGN N/A
- Revenue Growth
- TRAK 9.73
- ENGN N/A
- 52 Week Low
- TRAK $15.12
- ENGN $2.65
- 52 Week High
- TRAK $25.01
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- TRAK 54.01
- ENGN 77.94
- Support Level
- TRAK $16.86
- ENGN $5.52
- Resistance Level
- TRAK $17.39
- ENGN $6.54
- Average True Range (ATR)
- TRAK 0.47
- ENGN 0.55
- MACD
- TRAK 0.13
- ENGN 0.11
- Stochastic Oscillator
- TRAK 75.94
- ENGN 99.17
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.